Astra Zeneca – Global

INCREASING CAPACITY WITHOUT ADDITIONAL CAPITAL INVESTMENT

 

As a leading global pharmaceutical and biologic company, AstraZeneca needed a system that could simplify and enhance their complex processes as well as work with their current Lean Operation initiatives. AstraZeneca improved flexibility, responsiveness and quality by aligning TrakSYS™ to DMAIC (Define, Measure, Analyze, Improve, Control) principles. With OEE improvements of 10-40% reported across multiple lines, AstraZeneca increased capacity without additional capital investment and was able to produce an additional 1 million bottles per year without additional capital investment.

 

AstraZeneca’s Lean operations, paired with TrakSYS™, had goals to:

 

  • Identify root causes of equipment downtime and become proactive
  • Bottom line improvements of 10% in the first year
  • Automate OEE data collection in formulation and packaging areas to improve visibility and Business Intelligence (BI)

 

 

[pdf_attachment file=”1″ name=”Case Study – Astra Zeneca”]
Elisa Costa